FCGY yields 2000000.00% · PFE yields 6.13%● Live data
📍 FCGY pulled ahead of the other in Year 1
Combined, FCGY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FCGY + PFE for your $10,000?
Forecastagility Corporation provides legacy application migration solutions to corporate clients in the United States and internationally. The company develops toolsets that migrate RPG and COBOL applications written for the IBM i-AS/400 environment to open platforms, such as Windows, Linux, or UNIX; and toolsets and services to modernize green screen applications for AS/400 and Mainframe environments. Its products include BABYi, a standard edition developer toolset and application server environment to migrate AS/400 RPG and COBOL applications to Windows; and BABY36 developer toolset, a suite of compilers, utilities, and operating system services that allow applications to be rehosted at the source code level, and recompiled and executed on the target platform. The company's products also comprise Infinite i, a suite of compilers, utilities, and operating system services that allow applications and programs to be migrated at the source code level, recompiled, and executed on the target platform; Infinite36 that migrates IBM System/36 RPG and COBOL applications to Windows, Linux, or UNIX; Infinite Cloud that create graphical screens from IBM i/AS400 green screens; and Infinite I Database Migration Tool for DB2 for IBM I (DB2/400) that enables to migrate IBM I, iSeries, and AS/400 data to Oracle or MS SQL environment. In addition, it offers migration and GUI creation services. The company was formerly known as Infinite Software Corporation and changed its name to Forecastagility Corporation in June 2019. Forecastagility Corporation was founded in 1975 and is based in Irvine, California.
Full FCGY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.